one8zero8 LLC Acquires Shares of 43,940 Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

one8zero8 LLC bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 43,940 shares of the company’s stock, valued at approximately $1,742,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Nisa Investment Advisors LLC grew its holdings in shares of Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. Atria Investments Inc grew its holdings in shares of Acadia Healthcare by 4.7% in the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after purchasing an additional 308 shares in the last quarter. Pacer Advisors Inc. grew its holdings in shares of Acadia Healthcare by 2.4% in the fourth quarter. Pacer Advisors Inc. now owns 13,847 shares of the company’s stock valued at $549,000 after purchasing an additional 325 shares in the last quarter. KBC Group NV grew its holdings in shares of Acadia Healthcare by 14.4% in the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after purchasing an additional 338 shares in the last quarter. Finally, Tidal Investments LLC grew its holdings in shares of Acadia Healthcare by 7.9% in the third quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock valued at $296,000 after purchasing an additional 340 shares in the last quarter.

Acadia Healthcare Stock Up 1.3 %

NASDAQ:ACHC opened at $28.54 on Friday. Acadia Healthcare Company, Inc. has a twelve month low of $27.61 and a twelve month high of $82.40. The company has a market cap of $2.65 billion, a price-to-earnings ratio of 9.36, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. The stock has a fifty day simple moving average of $40.15 and a 200-day simple moving average of $48.52. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ACHC. Royal Bank of Canada cut their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price target for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. KeyCorp lowered their price target on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday, March 3rd. Finally, Barclays downgraded Acadia Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price target for the stock from $43.00 to $35.00 in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $56.31.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.